Efstathios Karathanasis

3.1k total citations
49 papers, 2.5k citations indexed

About

Efstathios Karathanasis is a scholar working on Biomaterials, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Efstathios Karathanasis has authored 49 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Biomaterials, 29 papers in Biomedical Engineering and 10 papers in Molecular Biology. Recurrent topics in Efstathios Karathanasis's work include Nanoparticle-Based Drug Delivery (30 papers), Nanoplatforms for cancer theranostics (18 papers) and Immunotherapy and Immune Responses (8 papers). Efstathios Karathanasis is often cited by papers focused on Nanoparticle-Based Drug Delivery (30 papers), Nanoplatforms for cancer theranostics (18 papers) and Immunotherapy and Immune Responses (8 papers). Efstathios Karathanasis collaborates with scholars based in United States and United Kingdom. Efstathios Karathanasis's co-authors include Randall Toy, Ketan B. Ghaghada, Pubudu M. Peiris, Ananth Annapragada, Ravi V. Bellamkonda, Lisa Bauer, Elliott Hayden, Gil Covarrubias, Prabhani U. Atukorale and Harihara Baskaran and has published in prestigious journals such as ACS Nano, PLoS ONE and Biomaterials.

In The Last Decade

Efstathios Karathanasis

49 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Efstathios Karathanasis United States 27 1.3k 1.3k 721 411 313 49 2.5k
Shrey Sindhwani Canada 19 1.7k 1.3× 1.4k 1.1× 1.0k 1.4× 579 1.4× 305 1.0× 23 3.0k
Presley MacMillan Canada 11 1.7k 1.3× 1.5k 1.1× 1.0k 1.5× 467 1.1× 360 1.2× 12 2.8k
Benjamin R. Kingston Canada 15 1.8k 1.4× 1.5k 1.2× 1.3k 1.8× 608 1.5× 441 1.4× 18 3.3k
Haiqiang Cao China 19 1.8k 1.4× 1.0k 0.8× 892 1.2× 471 1.1× 364 1.2× 28 2.5k
Yuwei Zhang China 17 1.7k 1.3× 1.4k 1.1× 1.3k 1.8× 534 1.3× 433 1.4× 38 3.2k
Zachary P. Lin Canada 11 1.4k 1.1× 1.2k 0.9× 858 1.2× 383 0.9× 283 0.9× 15 2.3k
Mi Kyung Yu South Korea 19 1.3k 1.0× 1.5k 1.1× 969 1.3× 629 1.5× 218 0.7× 25 2.7k
Rita E. Serda United States 29 1.3k 1.0× 856 0.7× 932 1.3× 868 2.1× 318 1.0× 77 2.8k
Chuan Hu China 27 1.9k 1.5× 1.4k 1.1× 1.1k 1.5× 403 1.0× 547 1.7× 38 3.0k
Xinyu He China 23 2.0k 1.5× 1.3k 1.0× 1.1k 1.5× 643 1.6× 453 1.4× 64 3.2k

Countries citing papers authored by Efstathios Karathanasis

Since Specialization
Citations

This map shows the geographic impact of Efstathios Karathanasis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Efstathios Karathanasis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Efstathios Karathanasis more than expected).

Fields of papers citing papers by Efstathios Karathanasis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Efstathios Karathanasis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Efstathios Karathanasis. The network helps show where Efstathios Karathanasis may publish in the future.

Co-authorship network of co-authors of Efstathios Karathanasis

This figure shows the co-authorship network connecting the top 25 collaborators of Efstathios Karathanasis. A scholar is included among the top collaborators of Efstathios Karathanasis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Efstathios Karathanasis. Efstathios Karathanasis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moon, Taylor J., et al.. (2025). Lipid Nanoparticles and PEG: Time Frame of Immune Checkpoint Blockade Can Be Controlled by Adjusting the Rate of Cellular Uptake of Nanoparticles. Molecular Pharmaceutics. 22(4). 1859–1868. 2 indexed citations
2.
Moon, Taylor J., et al.. (2023). Can targeted nanoparticles distinguish cancer metastasis from inflammation?. Journal of Controlled Release. 362. 812–819. 2 indexed citations
3.
Hamedani, Hoda Amani, Yi Yang, Haochen Wang, et al.. (2023). Flexible multifunctional titania nanotube array platform for biological interfacing. MRS Bulletin. 49(4). 299–309. 2 indexed citations
4.
Covarrubias, Gil, Mette L. Johansen, Jason Vincent, et al.. (2020). PTPmu-targeted nanoparticles label invasive pediatric and adult glioblastoma. Nanomedicine Nanotechnology Biology and Medicine. 28. 102216–102216. 9 indexed citations
5.
Atukorale, Prabhani U., Shruti Raghunathan, Taylor J. Moon, et al.. (2019). Nanoparticle Encapsulation of Synergistic Immune Agonists Enables Systemic Codelivery to Tumor Sites and IFNβ-Driven Antitumor Immunity. Cancer Research. 79(20). 5394–5406. 72 indexed citations
6.
Covarrubias, Gil, Morgan E. Lorkowski, Bernadette O. Erokwu, et al.. (2018). Imaging breast cancer using a dual-ligand nanochain particle. PLoS ONE. 13(10). e0204296–e0204296. 15 indexed citations
7.
Peiris, Pubudu M., Elizabeth Doolittle, Randall Toy, et al.. (2015). Treatment of Invasive Brain Tumors Using a Chain-like Nanoparticle. Cancer Research. 75(7). 1356–1365. 59 indexed citations
8.
Peiris, Pubudu M., Partha Deb, Elizabeth Doolittle, et al.. (2015). Vascular Targeting of a Gold Nanoparticle to Breast Cancer Metastasis. Journal of Pharmaceutical Sciences. 104(8). 2600–2610. 46 indexed citations
9.
Toy, Randall, Lisa Bauer, Christopher Hoimes, Ketan B. Ghaghada, & Efstathios Karathanasis. (2014). Targeted nanotechnology for cancer imaging. Advanced Drug Delivery Reviews. 76. 79–97. 137 indexed citations
10.
Peiris, Pubudu M., Randall Toy, Lisa Bauer, et al.. (2013). Treatment of cancer micrometastasis using a multicomponent chain-like nanoparticle. Journal of Controlled Release. 173. 51–58. 40 indexed citations
11.
Peiris, Pubudu M., Randall Toy, Lisa Bauer, et al.. (2013). On-Command Drug Release from Nanochains Inhibits Growth of Breast Tumors. Pharmaceutical Research. 31(6). 1460–1468. 14 indexed citations
12.
Toy, Randall, et al.. (2011). The effects of particle size, density and shape on margination of nanoparticles in microcirculation. Nanotechnology. 22(11). 115101–115101. 193 indexed citations
13.
McNeeley, Kathleen M., Efstathios Karathanasis, Ananth Annapragada, & Ravi V. Bellamkonda. (2009). Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors. Biomaterials. 30(23-24). 3986–3995. 104 indexed citations
14.
Karathanasis, Efstathios, Leslie W. Chan, Lohitash Karumbaiah, et al.. (2009). Tumor Vascular Permeability to a Nanoprobe Correlates to Tumor-Specific Expression Levels of Angiogenic Markers. PLoS ONE. 4(6). e5843–e5843. 56 indexed citations
15.
Karathanasis, Efstathios, Cissy Geigerman, Charles A. Parkos, et al.. (2009). Selective Targeting of Nanocarriers to Neutrophils and Monocytes. Annals of Biomedical Engineering. 37(10). 1984–1992. 27 indexed citations
16.
Karathanasis, Efstathios, Sankararaman Suryanarayanan, Kathleen M. McNeeley, et al.. (2009). Imaging Nanoprobe for Prediction of Outcome of Nanoparticle Chemotherapy by Using Mammography. Radiology. 250(2). 398–406. 80 indexed citations
17.
Karathanasis, Efstathios, Jae-Keun Park, Fuqiang Zhao, et al.. (2008). MRI mediated, non-invasive tracking of intratumoral distribution of nanocarriers in rat glioma. Nanotechnology. 19(31). 315101–315101. 17 indexed citations
18.
Karathanasis, Efstathios, Leslie W. Chan, Carl J. D’Orsi, et al.. (2008). Multifunctional nanocarriers for mammographic quantification of tumor dosing and prognosis of breast cancer therapy. Biomaterials. 29(36). 4815–4822. 49 indexed citations
19.
Karathanasis, Efstathios, et al.. (2004). Preparation of in vivo cleavable agglomerated liposomes suitable for modulated pulmonary drug delivery. Journal of Controlled Release. 103(1). 159–175. 46 indexed citations
20.
Bhavane, Rohan, Efstathios Karathanasis, & Ananth Annapragada. (2003). Agglomerated vesicle technology: a new class of particles for controlled and modulated pulmonary drug delivery. Journal of Controlled Release. 93(1). 15–28. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shrey Sindhwani Breakdown of academic impact, for papers by Presley MacMillan Breakdown of academic impact, for papers by Benjamin R. Kingston Breakdown of academic impact, for papers by Haiqiang Cao Breakdown of academic impact, for papers by Yuwei Zhang Breakdown of academic impact, for papers by Zachary P. Lin Breakdown of academic impact, for papers by Mi Kyung Yu Breakdown of academic impact, for papers by Rita E. Serda Breakdown of academic impact, for papers by Chuan Hu Breakdown of academic impact, for papers by Xinyu He
Rankless by CCL
2026